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Purpose: Major depressive disorder (MDD) is a debilitating human health condition
characterized by mood swings and is associated with a high probability of suicide attempts.
Several studies have reported a role of neuroinflammation in MMD, yet the efficacy of
natural drug substances on neuroinflammation-associated depression has not been wellinvestigated. The present study examined the neuroprotective effects of carvacrol on lipo
polysaccharide (LPS)-induced neuroinflammation, depression, and anxiety-like behavior.
Methods: Male Sprague Dawley rats were divided into two experimental cohorts to
determine the effects and the effective dose of carvacrol (whether 20 mg/kg or 50 mg/kg),
and further demonstrate the mechanism of action of nuclear factor E2-related factor (Nrf2) in
depression.
Results: We found marked neuronal alterations in the cortex and hippocampus of LPSintoxicated animals that were associated with higher inflammatory cytokine expression such
as cyclooxygenase (COX2), tumor necrosis factor-alpha (TNF-α), and c-Jun N-terminal
kinase (p-JNK). These detrimental effects exacerbated oxidative stress, as documented by
a compromised antioxidant system due to high lipid peroxidase (LPO). Carvacrol (20 mg/kg)
significantly reverted these changes by positively modulating the antioxidant gene Nrf2,
a master regulator of the downstream antioxidant pathway. To further investigate the role of
Nrf2, an inhibitor of Nrf2 called all-trans retinoic acid (ATRA) was used, which further
exacerbated LPS toxicity with a higher oxidative and inflammatory cytokine level. To further
support our notion, we performed virtual docking of carvacrol with the Nrf2-Keap1 target
and the resultant drug-protein interactions validated the in vivo findings.
Conclusion: Collectively, our findings suggest that carvacrol (20 mg/kg) could activate the
endogenous master antioxidant Nrf2, which further regulates the expression of downstream
antioxidants, eventually ameliorating LPS-induced neuroinflammation and neurodegeneration.
Keywords: depression, neuroinflammation, Nrf2 pathway, lipopolysaccharide, carvacrol,
neurodegeneration

Introduction

Shupeng Li
State Key Laboratory of Oncogenomics,
School of Chemical Biology and
Biotechnology, Shenzhen Graduate
School, Peking University, Shenzhen,
518000, People's Republic of China
Email lisp@pku.edu.cn

Major depressive disorder (MDD) is a devastating human health disorder that is
characterized by feelings of worthlessness, lack of motivation, altered mood, and
recurrent thoughts of suicide, along with a higher prevalence of suicide.1,2
Moreover, depression is known to be the second-leading cause of disease burden
for developed countries by 2020 as per the World Health Organization.3 Although
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extensive research is underway on existing antidepressants
that target the serotonin and/or norepinephrine systems,
the risk-benefit ratio demands subsequent alternatives.
Moreover, the usefulness of existing antidepressants is
further compromised due to delayed therapeutic response
and limited patient recovery.4 Furthermore, the relatively
poor understanding of the mechanisms of antidepressant
therapy combined with the complicated prognosis of the
disease hinders the treatment strategies. Therefore, an indepth understanding of the mechanisms underlying this
disease is required to develop novel treatments for
depression.5
Multiple studies have proposed that oxidative stress and
inflammation can exacerbate the severity of MDD,6 as
a consistently high level of inflammatory cytokines is
found in MDD pathophysiology.7 The surge in cytokines
are directly related to the permeation of leukocytes and
granulocytes to the brain from the surrounding
vasculature.8 Moreover, resident glial cells are rapidly acti
vated and trigger the release of pro-inflammatory cytokines
such as interleukin-1 (IL-1β), tumor necrotic factor-alpha
(TNF-α), and interleukin-6 (IL-6), which clinically compro
mises the prognosis of MDD,9–11 Lipopolysaccharide
(LPS), a bacterial endotoxin, is frequently used to induce
behavioral deficits and neurodegeneration and thereby used
to model depression and anxiety in rodents.12–14 The exact
mechanism of LPS-induced neurodegeneration is not
known, but multiple studies suggest the involvement of
Toll-like receptor (TLR)-4, whose activation leads to ele
vated levels of inflammatory mediators.15 The cross-talk of
inflammation and oxidative stress significantly perturbs cer
tain antioxidant proteins such as Nrf-2 and heme oxyge
nase-1 (HO-1).16–19
The transcription factor Nrf2 is an integral part of the
host cellular defense mechanism against oxidative stress
and electrophilic insult. Nrf2 binds to antioxidant response
elements (ARE) at promoter sites of genes that encode
several antioxidant/phase-II detoxifying enzymes and
other relevant stress-responding factors.20 Previous studies
revealed the involvement of Nrf2-ARE signaling in attenu
ating inflammation in several pathologies such as stroke
and other disorders.21–23 Hence, dysregulation of Nrf2
signaling results in increased susceptibility to oxidative
stress and inflammatory damage.24,25 Moreover, the neu
roprotective role of Nrf2 in various neurodegenerative
disease models has been reported.26 Previous studies
demonstrated that Nrf2 plays a critical role in the regula
tion of inflammation and oxidative stress, two processes
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that are linked to the pathophysiology of depression.27,28
Therefore, Nrf2 might be considered a potential pharma
cological target for the investigation of depressive
behaviors.
Natural drug moieties are an attractive source of new
drugs, owing to their rich antioxidant potential. Several
natural drugs have protective potential against a variety of
mediators, including free radicals and inflammatory
factors.29 Carvacrol (5-isopropyl-2-methyl phenol),
a monoterpene phenol, is extracted as an essential oil
from the plant family Labiatae, including the genera
Thymbra, Origanum, Satureja, and Thymus.30 Carvacrol
possesses favorable biological activities possibly due to its
antioxidant and anti-inflammatory properties.30 Previously
carvacrol demonstrated neuroprotective effects in ischemic
brain injury by attenuating infarction area.31 Furthermore,
carvacrol also attenuated behavioral deficits and memory
impairment in a rat model possibly by enhancing brainderived neurotrophic factor (BDNF) associated with
a decreased expression of TLR4 mRNA.32 In another
study, Melo et al demonstrated that carvacrol can mitigate
depression-like symptoms by modulating dopamine
levels.33 Similarly, carvacrol attenuated ethanol-induced
cognitive deficits by modulating MAPK cascade and mito
chondrial pathways.34 Taking into consideration the phar
macological value of essential oils and the significance of
new drug discovery, the current study aimed to investigate
whether carvacrol administration can ameliorate LPSinduced behavioral deficits, neurodegeneration, and the
neuroinflammatory cascades in an animal model by target
ing the Nrf2-signaling pathway. As per our information
and literature survey, we for the first time demonstrated
that carvacrol mediated anxiolytic and anti-depressant
effects by promoting the Nrf2 dependent downregulation
of inflammatory cascades.

Materials and Methods
Chemicals and Reagents
Carvacrol (W224502), glutathione (GSH), trichloroacetic
acid
(TCA),1-Chloro-2,4-dinitrobenzene
(CDNP),
N-(1-Naphthyl) ethylenediamine dihydrochloride, 5,5′Dithio-bis-(2-nitrobenzoic acid) (DTNB), LPS, and all-trans
retinoic acid (ATRA) were purchased from Sigma-Aldrich
(St. Louis, MO, USA). Primary antibodies such as mouse
monoclonal anti-HO-1 (SC-136960), mouse monoclonal
anti–TNF-α (SC-52B83), mouse monoclonal anti–p-NFκB
(SC-271908), rabbit polyclonal anti-Nrf2 (SC-722), mouse

Journal of Inflammation Research 2021:14

Journal of Inflammation Research downloaded from https://www.dovepress.com/ by 13.52.65.12 on 18-Apr-2021
For personal use only.

Dovepress

monoclonal anti-caspase-3 (31A1067), mouse monoclonal
anti-Bcl-2 (sc-7382), an ABC Elite kit, and 3,3′-diaminoben
zidine peroxidase (DAB) were purchased from Santa Cruz
Biotechnology USA. The horseradish peroxidase-conjugated
secondary antibody was obtained from Abcam UK (ab6789). ELISA kits for p-NF-kB (Cat # SUB28069) and
Nrf2 (cat. no. SU-B30429) were procured from Shanghai
Yuchun Biotechnology (China), and HO-1 (cat. No. E-ELR0488) and TNF-α (cat. No. E-EL-R0019) ELISA kits were
purchased from Elabscience.

Animals
Male Sprague Dawley rats weighing 180–200 g were
housed three per cage under a 12 hour light/dark cycle
with free access to water and food at the animal house of
Riphah Institute of Pharmaceutical Sciences (RIPS) under
standard laboratory protocols (temperature: 22±1°C;
humidity: 50%±10%). All experimental procedures were
carried out according to the guidelines of the Institute of
Laboratory Animal Resources, Commission on Life
Sciences University, National Research Council (1996),
approved by the RIPS Ethical Committee (Reference No:
REC/RIPS/2017/010).

Experimental Outline
Two separate cohorts of animals were used in this study.
The first cohort included five groups (n = 10 animals/
group): 1) saline (10 mL/kg with 5% DMSO), 2) LPS
(1 mg/kg), 3) LPS + CAR 20 (carvacrol; 20 mg/kg), 4)
LPS + CAR 50 (carvacrol; 50 mg/kg), and 5) LPS + FLX
(fluoxetine; 5 mg/kg). The second cohort included three
groups:1) LPS + ATRA, 2) CAR (20 mg/kg) + ATRA +
LPS, and 3) FLX + ATRA + LPS (n = 8 animals/group).
Carvacrol and fluoxetine were dissolved in normal saline
containing 5% DMSO and administered once daily (i.p.)
for five consecutive days (Figure 1). On days three and
four, the animals received LPS (1 mg/kg, i.p.) 1h after the
carvacrol/fluoxetine injection.35 On day five, after the last
carvacrol/fluoxetine injection, animals were analyzed for
depressive- and anxiety-like behaviors (ie, despair) by the
sucrose splash test (SST), elevated plus maze (EPM) test,
light-dark box (LDB) test, and forced swim test (FST).
Following the behavioral tests, the animals were termin
ally anesthetized with sodium pentobarbital (60 mg/kg,
i.p.). Brain tissues were extracted from the prefrontal
cortex and hippocampus and were snap-frozen and stored
at –80°C. ATRA dissolved in normal saline containing 5%
DMSO was administered 30 min before LPS
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administration (i.p.). Carvacrol (20 mg/kg) and fluoxetine
were administered as described above.

Behavioral Studies
Sucrose Splash Test (SST)
The SST was performed to evaluate the depressive-like
behavior of rats and was conducted as previously
reported.36 Grooming behavior indicates depressive symp
toms measured by time in seconds. The shorter the time of
grooming behavior, the higher the level of depression. The
test was performed by spraying a 10% sucrose solution on
the dorsal surface of the rodent’s body, and grooming
behavior was measured in terms of licking, biting, or
scratching the fur to clean the solution off. Grooming
time was videotaped for 5 min.

Elevated Plus-Maze (EPM) Test
An EPM test was conducted to measure LPS-mediated
anxiety-like behavior. Briefly, the maze equipment con
sisted of two oppositely facing open arms and two oppo
sitely facing closed arms (OA, 50 × 10 cm; CA, 50 ×
10 cm) in the form of a cross-shaped Plexiglas platform
with 40 cm walls and a height of 50 cm above the floor in
a soundproof room with dim light. Each rat was placed at
the central point of the Plexiglas platform with its head
facing any open arm. The time spent and the number of
entries in each arm were recorded for all animals for
5 min.37

Light-Dark Box (LDB) Test
The LDB test was performed to assess LPS-mediated
anxiety-like behavior. LDB equipment comprises of
a light and a dark compartment separated by a partition
containing a small gap. Each animal was placed in the
dark compartment of a light-dark box and was set to freely
move around the box for 5 min. The total number of
entries and time spent in each compartment was video
taped. Olfactory cues were minimized by ensuring thor
ough cleaning of the light-dark box with alcohol between
tests.38

Forced Swim Test (FST)
The rat was placed in a Plexiglas cylinder that was 70 cm in
height and 30 cm in diameter and filled with water above
a 30 cm height at a temperature of 23±1°C and then video
taped for 7 min. The last 4 min were randomly assessed at 5
s intervals.35 Climbing, swimming, and floating were the
predominant behaviors observed during each 5 s interval.
Rats were categorized as immobile when they floated in
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Figure 1 Experimental outline.

a motionless manner while showing only movements that
were necessary to keep their heads above the surface of the
water. Horizontal movements were considered swimming
and vertical movements were taken as climbing.

Antioxidant Assays
Determination of Lipid Peroxidation (LPO)
The procedure to determine lipid peroxidation in tissue
was followed as previously reported.39 Cortical and hip
pocampal tissues of each rat were homogenized separately
in 10 mL of 20 mM Tris-HCl at 4 °C while maintaining
pH at 7.4 in the Polytron homogenizer. The homogenate
was then centrifuged at 1000 g for 10 min at 4 °C and the
supernatant was collected. A fresh solution of ferric
ammonium sulfate was prepared. Forty microliters of the
above solution were added to the collected supernatant,
which was then incubated at 37 °C for 30 min. Then, a
0.8% solution of 2-thiobarbituric acid (TBA) was prepared
by dissolving 400 mg in 50 mL of water. A total of 75 μL
of TBA was added to the mixture of the supernatant and
ferric ammonium sulfate. Absorbance was measured at
a wavelength of 532 nm using a plate reader.

Reduced Glutathione (GSH) Activity
The reduced glutathione (GSH) activity was measured
with some modification to what has been previously
described.40 Each well contained 40 μL of 0.6 mM
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DTNB in 0.2 M sodium phosphate while maintaining pH
at 8, followed by the addition of 6.6 μL of sample and
153 μL of phosphate buffer to each well. Absorbance was
recorded using a plate reader at a wavelength of 412 nm.

Glutathione-S-Transferase (GST) Activity
GST activity was measured using CDNB as a substrate, as
described previously with a slight modification.41 Each well
was filled with 10 μL of 1 mM CDNB, 10 μL of 5 mM reduced
glutathione, 270 μL of buffer solution, and 10 μL of the sample.
The absorbance was read at 340 nm using a plate reader.

Catalase Activity
Catalase activity was measured by mixing 3 mL of H2O2 and
0.05 mL of tissue supernatant. The absorbance activity was
measured at 240 nm against a blank containing 3 mL of PBS
only. The absorbance is proportional to the H2O2 level, which
is decreased by catalase as it degrades the H2O2. This is the
measure of H2O2 breakdown and hence is expressed as μmol
H2O2 decomposed per mg of protein/min.42

Histological Preparation
Rats were decapitated after the behavioral tests, followed by
the extraction of brain tissues. Three mm thick sections were
cut using a sharp blade and fixed in a 4% paraformaldehyde
solution. The tissues were embedded into paraffin blocks and
trimmed to 4μm thin coronal sections using a microtome, and
following staining techniques were applied.
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Hematoxylin & Eosin (H&E) Staining
Absolute xylene was used to deparaffinize the tissuecoated slides, followed by rehydration with a gradient
ethanol concentration (100% to 70%). Slides were then
washed with distilled water and rinsed with the hematox
ylin stain for 10 min to localize the nucleus. The slides
were then kept under running water in a glass jar for
10 min and treated with 1% HCl and 1% ammonia water
as reported previously.43 Eosin solution was used after
ward for 5–10 min for cytoplasmic staining. After the
specified time, slides were rinsed with water and airdried for a short interval. Graded concentrations (70%,
95%, and 100%) of ethanol were used to rehydrate the
slides, which were then cleared with xylene. Finally, the
slides were coverslipped using mounting media. A light
microscope (Olympus, Japan) was used to capture images
of the brain sections. Images were then analyzed using
ImageJ software. Five images per slide per group were
analyzed with a specific focus on identifying infiltrations,
vacuole formation, and neuronal survival. For all groups,
images of the same threshold intensity were optimized in
the TIFF format.

Immunohistochemical Analysis
We employed a previously described procedure with slight
modifications for immunohistochemical analysis.44 After com
pletion of the deparaffinization step, slides were processed by
an enzymatic method for antigen retrieval, and then washed
with PBS consecutively three times for 5 min. Slides were
immersed in 3% H2O2 to quench endogenous peroxidase
activity followed by washing with PBS. Normal goat serum
(5%) was applied as a blocking serum and slides were incu
bated for 2 h. Next, the slides were incubated overnight with
primary antibodies Bcl2, Caspase 3, TNF-α, and p-NFκB. The
next morning, slides were washed with PBS and incubated for
90 min with the secondary antibody, then incubated with an
ABC kit (Santa Cruz) in a humidified box for 60 min. Slides
were then washed with PBS solution and stained with DAB,
followed by dehydration with ethanol (70%, 80%, 90%, and
100%). After dehydration, slides were fixed with xylene and
then coverslipped with mounting media. Images were obtained
using a light microscope and saved in TIFF format for further
quantification by ImageJ software.

ELISA Analysis
Approximately 70 mg of cortical tissue was homogenized
in PBS containing phenylmethylsulfonyl fluoride (PMSF)
as a protease inhibitor using a Silent Crusher
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M (Heidolph-Germany). The resultant homogenate was
then centrifuged at 15,000 rpm at 4°C for 20 min, and
the supernatant was carefully collected from the top,
avoiding the pellet at the bottom. The protein concentra
tion was then determined for each group using
a bicinchoninic acid (BCA) kit (Thermo Fisher Scientific,
USA) and protein concentration was determined using 96well ELISA plates according to the manufacturer proto
cols. The readings were taken using an ELISA microplate
reader (BioTek ELx808) and the concentration (pg/mL)
was then normalized to the total protein content (pg/mg
total protein).

Western Blot
All the samples were homogenized using lysis buffer (1M
Tris-HCl, 5 M NaCl, sodium deoxycholate 0.5%, sodium
dodecyl sulfate 10%, sodium azide 1%, and NP-40 10%)
further supplemented with a protease inhibitor (PMSF).
After centrifugation, the protein concentration of the lysate
was determined using a BCA method (Pierce, Rockford,
IL, United States) following the guidelines of the manu
facturer. An equal amount of protein (30 µg per sample)
was electrophoresed on 10% SDS-PAGE gels, followed by
transferring the protein to polyvinylidene fluoride (PVDF)
membranes (Millipore, Billerica, MA, United States).
After blocking the PVDF membranes using skim milk to
reduce binding of the nonspecific protein binding, the
PVDF membrane was incubated at 4°C for the whole
night with the primary antibodies against rat anti-Nrf2,
mouse anti-HO-1. β-actin was used as a loading
control.45,46 The following day, membranes were incu
bated with secondary antibodies, and western bands were
visualized on x-ray film using ECL detection reagent fol
lowing the instructions of the manufacturer (Amersham
Pharmacia Biotech, Piscataway, NJ, United States).

Molecular Docking
Molecular docking was performed using the GOLD v5.2.2
(Genetic Optimization of Ligand Docking) package.47 The
3D structure of Keap1 in complex with the RA839 inhi
bitor (PDB ID: 5CGJ) was retrieved from the RCSB
protein data bank.48 Keap1 was removed from all heteroa
toms, water molecules, and other non-desirable entities
before initiating the docking simulation, followed by the
addition of hydrogen atoms and detection of the Keap1
docking site from the attached inhibitor (RA839). The
online database PubChem was used to retrieve the 2D
structure of carvacrol, which was then processed for
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docking in DS v4.5 (Discovery Studio). Following the
docking protocol, approximately 100 different conforma
tions of carvacrol were created by employing the genetic
algorithm (GA) of the GOLD package. Moreover, the
scoring function was performed and the results were ana
lyzed using the software ChemPLP (piecewise linear
potential). The highest value of ChemPLP determined the
best inhibitory confirmation as well as polar and non-polar
interactions of carvacrol with the active binding residues
of Keap1. Assessment and interpretation of docking results
were carried out using DS and GOLD packages.

Statistical Analysis
The results obtained were expressed as mean ± standard error
of the mean (SEM) and statistically analyzed by applying oneway ANOVA followed by Bonferroni multiple comparisons
as post-hoc. A value of p<0.05 was considered statistically
significant. The bar graphs were analyzed using GraphPad
Prism 6.0 (GraphPad, San Diego, CA, USA). The symbol #
shows a significant difference relative to the saline group, and

Dovepress

* shows a significant difference relative to the LPS group,
while $ represents a significant difference to ATRA + LPS.

Results
Effects of Carvacrol on the LPS-Induced
Behavioral Deficit
LPS-treated animals demonstrated a significant decrease in
exploratory behavior as shown by the fewer entries to the
open arms in the EPM test and by less time spent in the
open arms compared to the saline group (Figure 2A and B,
###
p<0.001). Similarly, LPS reduced struggling and heigh
tened immobility in the FST (Figure 2C and D,
###
p<0.001), caused a marked decrease in the number of
entries and duration in the light compartment in the LDB
test (Figure 2E and F, ###p<0.001), and significantly
reduced grooming time in the SST (Figure 2G,
###
p<0.001). Carvacrol treatment (20 mg/kg) reversed the
LPS-induced behavioral deficits and was accompanied by
a greater number of entries and duration of time spent in
the open arms in the EPM test (Figure 2A and B,

Figure 2 Effects of carvacrol (CAR) on LPS-induced behavioral deficits. Effect of CAR and LPS on the EPM test (A and B), FST (C and D), LDB test (E and F), and SST (G).
Data are expressed as means ± SEM and analyzed by one-way ANOVA followed by Bonferroni multiple comparisons test using GraphPad Prism 6 software. Saline, LPS, CAR
+LPS, and FLX+LPS groups represent the first cohort (n=10/group), while the LPS+ATRA, CAR+ATRA+LPS, and FLX+ATRA+LPS were from the second cohort (n=8/
group). ###p<0.001 and ##p<0.01 indicates a significant difference compared to the saline group and *p<0.05, **p<0.01, ***p<0.001 is compared to the LPS group.
Abbreviations: CAR, carvacrol; LPS, lipopolysaccharide; ATRA, all-trans retinoic acid; FLX, fluoxetine; EPM, elevated plus maze; FST, forced swim test; LDB, light-dark box;
SST, sucrose splash test.
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**p<0.01, 20 mg/kg). Furthermore, carvacrol increased the
struggling capacity (Figure 2C, ***p<0.001) and alle
viated immobility (Figure 2D, **p<0.01) in the FST.
Similarly, the 20 mg/kg dose of carvacrol increased the
number of entries (Figure 2E, **p<0.01) and time spent in
the light compartment (Figure 2F, ***p<0.001), and was
associated with a higher grooming time (Figure 2G,
***p<0.001) in the SST. Treatment with the 50 mg/kg
dose of carvacrol did not significantly influence the mea
sures obtained in the EPM test, LDB test, or FST, but led
to an extended grooming time in the SST (Figure 2G,
*p<0.05). Moreover, co-treatment with LPS and ATRA
further exacerbated the anxiety-like behavioral deficits,
whereas treatment with carvacrol did not elicit any ameli
orative effects on LPS-induced behavioral deficits in
ATRA-treated groups (second cohort).

Effects of Carvacrol on LPS-Induced
Histopathological Changes
HE staining results revealed significant histopathological
changes in LPS-treated animals (Figure 3, ###p<0.001).

Naeem et al

Significant alterations were observed in the LPS group com
pared to saline-treated animals. The saline group showed
a normal pyramidal cell shape with a well-demarcated
round nucleus (Figure 3). There was no vacuolization or
lipid globules, and all neurons exhibited a relative basophilic
cytoplasm. Nevertheless, many histopathological alterations
were observed in the LPS-treated groups, including multiple
vacuoles. Many neurons lacked dendrites and were encircled
by peri-cellular halos (Figure 3). Carvacrol administration
caused marked mitigation of these changes. Therefore, a high
degree of cellular integrity was evident in the carvacrol
(20 mg/kg)-treated group (Figure 3, cortex: ***p<0.001,
CA3: **p<0.01). Nevertheless, carvacrol pretreatment in
the ATRA-treated groups did not result in any improvement
of the LPS-induced histopathological changes.

Effects of Carvacrol on LPS-Induced
Apoptosis
We further demonstrated the anti-apoptotic action of carva
crol by measuring the level of p-JNK in the cortex of all
treated groups (Figure 4A). LPS treatment increased p-JNK

Figure 3 Hematoxylin and eosin (H&E) staining showing the extent of surviving neurons in the cortex and hippocampus (Corno amonus, CA). Scale bar 50 μm,
magnification 40×. Dead neurons were characterized by a swollen cytoplasm, vacuolization, scalloped morphology with intense cytoplasmic eosinophilia, and nuclear
basophilia. Data are expressed as means ± SEM. ###p<0.001 indicates a significant difference compared to the saline group, *p<0.05, **p<0.01, ***p<0.001 is compared to the
LPS group and $p<0.05 is compared to ATRA+LPS group. CAR 20: carvacrol (20 mg/kg); CAR 50: carvacrol (50 mg/kg); LPS: lipopolysaccharide; ATRA: all-trans retinoic acid;
FLX: fluoxetine. The H & E slides were made after the euthanization of animals following behavioral analysis. The saline, LPS, CAR+LPS, and FLX+LPS groups were those
studied in the first cohort (n=5/group), while the LPS+ATRA, CAR+ATRA+LPS, and FLX+ATRA+LPS groups were from the second cohort (n=4/group).
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levels (Figure 4A, ##p<0.01), while carvacrol pretreatment
attenuated this increase (Figure 4A, **p<0.01). To further
validate the expression of apoptotic marker caspase-3 and
anti-apoptotic marker Bcl-2, we measured their expression in
the cortex and hippocampus by immunohistochemistry ana
lysis. The expression of the anti-apoptotic factor Bcl-2 was
markedly decreased in both the cortex and hippocampus of
the LPS-treated group (Figure 4B, ###p<0.001). Consistently,
the expression of the pro-apoptotic factor caspase-3 was
upregulated in the LPS-treated group (Figure 4C,
###
p<0.001). In line with the results of p-JNK, a significant
upregulation of the anti-apoptotic factor Bcl-2 was seen in
carvacrol-treated rats (Figure 4B, cortex: **p<0.01, CA3:
**p<0.01, DG: ***p<0.001), with a significant decrease in
the expression of proapoptotic caspase-3 factor in carvacroltreated rats (Figure 4C, cortex: **p<0.01, CA3: ***p<0.001,
DG: ***p<0.001 vs LPS group). However, carvacrol admin
istration did not attenuate LPS-induced apoptosis in the
ATRA-treated groups.

Effects of Carvacrol on LPS-Induced
Neuroinflammation
Due to the significant involvement of inflammatory media
tors in depression, we sought to determine whether carva
crol treatment can affect neuroinflammation. Therefore, we
studied the expression of TNF-α, COX-2, and p-NFkB in
the cortex by ELISA. The levels of both TNF-α and COX-2
in the LPS group were significantly increased compared to
the saline group (Figure 5A and B, ###p<0.001). Consistent
with the upregulated levels of TNF-α and COX-2, the
expression of p-NFkB was also markedly increased in the
cortex of the LPS group (Figure 5C, ###p<0.001). Carvacrol
pretreatment induced a significant downregulation of TNFα (Figure 5A, *p<0.05), COX-2 (Figure 5B, ***p<0.001),
and p-NFkB (Figure 5C, **p<0.01) expression in the cortex
of treated animals relative to the LPS group. For further
validation, we performed immunohistochemical analysis,
and the results revealed overexpression of TNF-α and
p-NFkB in both the cortex and hippocampus of LPS-treated
groups (Figure 5D and E), ###p<0.001). Carvacrol adminis
tration reduced the LPS-induced overexpression of TNF-α
in the cortex (Figure 5D, ***p<0.001) and hippocampus
(Figure 5D, **p<0.01). Similarly, carvacrol also attenuated
the LPS-induced overexpression of p-NFkB in the cortex
(Figure 5E, ***p<0.001) and hippocampus (Figure 5E,
**p<0.01). Moreover, co-treatment with LPS and ATRA
further exaggerated the neuroinflammatory markers, while
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treatment with carvacrol did not reverse the detrimental
effects of LPS in ATRA-treated groups.

Effects of LPS and Carvacrol on the
Expression of Nrf2 and Nrf2 Dependent
Downstream Antioxidant Protein HO-1
The antioxidant mechanism of carvacrol was explored by
measuring the expression of Nrf2 and the Nrf2 down
stream signaling protein HO-1. Western blot analysis
demonstrated that the Nrf2 expression level in the LPStreated group was significantly reduced compared to that
in the saline group (Figure 6A, #p<0.05). Consistent with
the downregulated expression of Nrf2, expression of the
downstream antioxidant protein HO-1 was also markedly
decreased in the cortex of the LPS-treated group in com
parison to the saline group (Figure 6A, #p<0.05).
Carvacrol administration induced significant upregulation
of Nrf2 and HO-1 in the cortex of treated animals relative
to the LPS group (Figure 6A, *p<0.05). To further vali
date, a noticeable upregulation was also observed for Nrf2
and HO-1 using ELISA analysis (Figure 6B, ***p<0.001
and **p<0.01). Nonetheless, ATRA-treated groups did not
exhibit a carvacrol-mediated upregulation of Nrf2 or HO1. Thus, these results provide a clear indication that carva
crol might possess an antioxidant action via activation of
the Nrf2/HO-1 signaling pathway.

Effects of Carvacrol Pretreatment on
LPS-Induced Lipid Peroxidation and
Antioxidant Enzymes
To determine the neuroprotective role of carvacrol against
LPS-evoked lipid peroxidation and oxidative stress, we
measured the levels of catalase, GSH, GST, and thiobarbi
turic acid reactive substances (TBARS) in both the hippo
campus and prefrontal cortex. Carvacrol administration
ameliorated oxidative stress and restored the expression
of antioxidant enzymes in both the hippocampus and pre
frontal cortex to varying degrees. Catalase, GSH, and GST
levels in the LPS-treated group were significantly lower
than those in the saline group (Figure 7A–F), ###p<0.001).
On the other hand, the level of TBARS showed a marked
elevation in both the hippocampus and prefrontal cortex of
LPS-treated rats compared to the saline group (Figure 7G
and H, ###p<0.001). Carvacrol treatment induced the pro
duction of catalase, GSH, and GST in both the cortex and
hippocampus (Figure 7A and B, **p<0.01; Figure 7C and
D, *p<0.05 and ***p<0.001; and Figure 7E and F,
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Figure 4 Effects of carvacrol on LPS-induced neuronal apoptosis. (A) p-JNK levels were measured by ELISA. Data are expressed as means ± SEM. ###p<0.001 indicates
a significant difference compared to the saline group and **p<0.01 is compared to the LPS group. (B) Immunohistochemistry results for Bcl-2 in the cortex and
hippocampus. Scale bar 50 µm, magnification 40×. Data are expressed as means ± SEM. ###p<0.001 indicates a significant difference compared to the saline group and
**p<0.01, ***p<0.001 is compared to the LPS group. (C) Immunohistochemistry results for caspase-3 in the cortex and hippocampus. Scale bar 50 µm, magnification 40×.
Data are expressed as means ± SEM. ###p<0.001 and ## p<0.01 indicates a significant difference compared to the saline group and **p<0.01, ***p<0.001 is compared to the
LPS group. The immunohistochemistry sections were prepared after the euthanization of animals following behavioral analysis. The Saline, LPS, CAR+LPS, and FLX+LPS
groups were taken as the first cohort (n=5/group), while the LPS+ATRA, CAR+ATRA+LPS, and FLX+ATRA+LPS groups were from the second cohort (n=4/group). For
ELISA analysis, animals were taken from both the first cohort (n=5/group) and the second cohort (n=4/group).
Abbreviations: CAR 20, carvacrol (20 mg/kg); CAR 50, carvacrol (50 mg/kg); LPS, lipopolysaccharide; ATRA, all-trans retinoic acid; FLX, fluoxetine; p-JNK, Jun N-terminal
kinase; Bcl-2, B cell lymphoma-2.
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Figure 5 Effects of carvacrol on LPS induced neuroinflammation. (A) TNF-α levels, (B) COX-2 levels, and (C) p-NFkB levels were measured by ELISA. Data are expressed
as means ± SEM. ###p<0.001 indicates a significant difference compared to the saline group, *p<0.05, **p<0.01 and ***p<0.001 is compared to the LPS group and $p<0.05 is
compared to ATRA+LPS group. (D) Immunohistochemistry results for TNF-α in the cortex and hippocampus. (E) Immunohistochemistry results for p-NFkB in the cortex
and hippocampus. Scale bar 50 µm, magnification 40×. Data are expressed as means ± SEM. ###p<0.001 indicates a significant difference compared to the saline group and
**p<0.01, ***p<0.001 is compared to the LPS group.
Abbreviations: CAR 20, carvacrol (20 mg/kg); CAR 50, carvacrol (50 mg/kg); LPS, lipopolysaccharide; ATRA, all-trans retinoic acid; FLX, fluoxetine; TNF-α, tumor necrosis
factor-alpha; COX-2, cycloxygenase-2); p-NFkB, nuclear factor-kappa B.

*p<0.05, and **p<0.01). However, a noticeable decline
was observed in the TBARS level of carvacrol-treated
rats in both the cortex and hippocampus compared to the
LPS group (Figure 7G and H, **p<0.01). Further, carva
crol pretreatment in the ATRA-treated groups did not
reveal any antioxidant or free-radical scavenging effects
(Figure 7), validating the Nrf2 results (Figure 6). Our
results demonstrated that carvacrol might participate in
free radical scavenging to ameliorate LPS-induced oxida
tive stress.

Molecular Docking
The above-mentioned results suggest that carvacrol acti
vates Nrf2 signaling, which is usually kept inactive when
bound to the downstream signaling protein Keap1.
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Therefore, we conducted a docking analysis of carvacrol
and Keap1 to explore the possible affinity of carvacrol for
binding Keap1 to interfere with the interaction between
Keap1 and Nrf2, thus facilitating the translocation of Nrf2
into the nucleus. Computational studies revealed efficient
binding of carvacrol with Keap1 and its orientation into
the Nrf2 binding pocket. The Nrf2 binding pocket desig
nated for Keap1 is shallow and it consists of three subregions: acidic, planner acceptor, and sulfamide (Figure
8).48 Hence, we first selected the appropriate subsite and
binding orientation of carvacrol in Keap1. The results
illustrated the orientation of carvacrol in two distinct stoi
chiometric conformations in the Nrf2 binding pocket of
Keap1 (Figure 8B and C). Carvacrol exhibited a docking
score of 35.08 and 37.14 after occupying the acidic and

Journal of Inflammation Research 2021:14

Journal of Inflammation Research downloaded from https://www.dovepress.com/ by 13.52.65.12 on 18-Apr-2021
For personal use only.

Dovepress

Naeem et al

Figure 6 Effects of carvacrol on LPS-induced downregulation of Nrf2 and HO-1. (A) Western blot analysis of Nrf2 and HO-1. Data are expressed as means ± SEM. #p<0.05,
##
p<0.01 compared to the saline group while *p<0.05 compared to the LPS group. (B) Nrf2 and HO-1 levels were measured by ELISA. Data are expressed as means ± SEM.
###
p<0.001 indicates a significant difference compared to the saline group and **p<0.01, ***p<0.001 compared to the LPS group.
Abbreviations: CAR 20, carvacrol (20 mg/kg); CAR 50, carvacrol (50 mg/kg); LPS, lipopolysaccharide; ATRA, all-trans retinoic acid; FLX, fluoxetine; Nrf2, nuclear factor
E2-related factor; HO-1, heme oxygenase 1.

sulfamide regions, respectively (Figure 8B and C), of the
Nrf2 binding pocket of Keap1 (Table 1). Moreover, the
interpretation of molecular interactions observed sug
gested that carvacrol shared two conventional hydrogen
bonds with Arg483 and Ser508 in the acidic sub-region of
Keap1 (Figure 8B and E). Furthermore, carvacrol also
formed a hydrogen bond with the residue SER602 in the
sulfamide sub-region of Keap1 (Figure 8C and F). Overall,
we propose that carvacrol orients in both the acidic and
sulfamide binding pockets of Keap1 and have established
hydrogen bonds with their respective binding residues
Arg483, Ser508, and Ser602. In addition to forming
hydrogen bonds with the active residues of Keap1, carva
crol also exhibited nonpolar interactions with binding resi
dues of the Nrf2 binding site of Keap1 (Figure 8, Table 1).
For instance, carvacrol established a nonpolar bond with
Tyr525, a binding residue that has already been reported
for interaction with some small molecule inhibitors of
Nrf2.49 Carvacrol demonstrated π-σ and alkyl interactions
in the sulfamide region with residues Arg415 and Ala556,
respectively (Figure 8C and F). In addition to polar inter
actions with the binding residue Arg415, carvacrol also
formed various nonpolar bonds including Van der Waal
and hydrophobic interactions with the Nrf2 amino acid
residues of the Keap1 binding pocket (Figure 8, Table 1).

Journal of Inflammation Research 2021:14

Hence, we speculate that carvacrol occupies the Nrf2
binding pocket of Keap1 and reduces the interaction of
Keap1 with Nrf2.

Discussion
Phytomedicine has been a great source of neuroprotective
agents in several neurodegenerative diseases. Lately, the
use of phytochemicals has increased; nevertheless, exten
sive research still needs to be conducted before phyto
chemicals can be approved as neuroprotectants and used
for treatment in human diseases.50 Previous literature has
revealed that carvacrol, a monoterpene, exhibits antioxi
dant, anti-inflammatory, and neuroprotective activities in
animal models of neurodegeneration.51 The present study
was designed to explore the antioxidant, anti-neuroinflam
matory, and neuroprotective action of carvacrol against
LPS-provoked anxiety and depression.
LPS-mediated depressive-like behaviors are character
ized by immobility with a simultaneous decrease in strug
gling time. Nevertheless, carvacrol pretreatment markedly
attenuated this behavioral despair by decreasing immobi
lity and increasing struggling time.52 Previous studies
demonstrated that increased immobility in the FST is
mediated by proinflammatory cytokines and a build-up of
reactive oxygen species (ROS) in the LPS model.53 Our
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Figure 7 Effects of carvacrol pretreatment on antioxidant enzymes and LPS-induced lipid peroxidation. Effects of LPS and CAR on levels of CAT (A and B); GSH (C and D);
GST (E and F), and TBARS (G and H). Data are expressed as means ± SEM. ###p<0.001 and ##p<0.01 indicates a significant difference compared to the saline group,
*p<0.05, **p<0.01, ***p<0.001 is compared to LPS group and $p<0.05 is compared to ATRA+LPS group.
Abbreviations: CAR, carvacrol; LPS, lipopolysaccharide; ATRA, all-trans retinoic acid; FLX, fluoxetine; CAT, catalase; GSH, reduced glutathione; GST, glutathioneS-transferase; TBARS, thiobarbituric acid reactive substances.

results attested to the previously reported data, that carva
crol can mitigate depression-like symptoms.33 Unlikely,
these authors also demonstrated a significant decrease in
immobility time in FST at a dose (carvacrol 50 mg/kg).
The possible discrepancy may due to species difference
and rate and route of carvacrol administration.
Additionally, we measured the grooming behavior in the
SST, which is considered an indicator of apathy and
decreased motivation. LPS administration caused
a noticeable reduction in grooming time, while carvacrol
pretreatment increased grooming time, showing a reversal
of LPS-induced apathy and lack of motivation. Our data
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demonstrated that carvacrol mitigates LPS-induced beha
vioral despair and apathy, thus improving the core symp
toms of depressive-like behaviors. Furthermore, we
evaluated anxiety-like behaviors by employing two fre
quently used paradigms, an EPM test, and an LDB test.
The data obtained from the EPM and LDB tests showed
the anxiolytic potential of carvacrol, as elevated values of
the open arm and lightbox parameters indicate anxiolytic
activity.54
Several studies have reported the involvement of ROS
in the pathophysiology of neurodegenerative diseases.55,56
Likewise, oxidative stress can exacerbate depression as the
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Figure 8 Retinoic acid and carvacrol bound to the Nrf2-binding site of Keap-1. The upper panel (A–C) illustrates the binding orientation of retinoic acid and carvacrol in the
Nrf2-binding site of Keap-1. A) Retinoic acid formed a conventional hydrogen bond with binding residue Arg483 of Keap-1. B) One carvacrol molecule established
a hydrogen bond with two binding residues Arg83 and Ser508 in the acidic region of Keap-1. C) Another carvacrol molecule constituted a hydrogen bond with amino acid
Ser602 in the sulfamide region of Keap-1. Retinoic acid and carvacrol are displayed as ball-and-stick models and are assigned green and purple colors, respectively. Keap-1
binding residues participating in either polar or non-polar interactions are represented as stick models. Conventional hydrogen bonds are illustrated as dotted lines in green
color. Other non-polar bonds are depicted as light pink–colored dotted lines. The lower panel (D–F) shows the two-dimensional interaction pattern of retinoic acid and
carvacrol with Keap-1. D) Retinoic acid and E) carvacrol in the acidic region of Keap-1, and F) carvacrol in the sulfamide region of Keap-1 show the established hydrogen
bonds with Keap-1. Retinoic acid and carvacrol are portrayed as ball-and-stick models and colored as green and purple, respectively. Hydrogen bonds forming binding
residues are illustrated in the form of labeled circles in green color. Conventional hydrogen bonds are demonstrated as green-colored dotted lines. Other hydrophobic
binding residues are shown as labeled circles in light green color (Van der Waals interactions) and light pink color (non-polar interactions).

brain has limited anti-oxidants combating capacity.57,58
This notion is further supported by the fact that several
clinically antidepressant drugs alleviated ROS in
depressed patients.59 The transcription factor Nrf2 and its
downstream signaling protein HO-1 constitute the major
cellular antioxidant system that regulates the gene

expression of several cytoprotective antioxidants. Our
results demonstrated that LPS stimulated the production
of ROS and led to an imbalance between oxidants and
endogenous antioxidants, and thus resulted in the build-up
of oxidative stress similar to that seen in previous
studies.60 Modulation of the Nrf2 pathway is considered

Table 1 Docking Scores and Hydrophobic Interactions of Retinoic Acid and Carvacrol with Keap-1
Inhibitor

Docking
Score

Hydrogen Bonds (<3.5Å)

Hydrophobic Interactions

Amino

Amino

Ligand

Distance

Acid

Acid

Atom

(Å)

Atom
Retinoic Acid

52.69

Arg483

HE

O2

2.8

Arg415, Ala556, Tyr525, Ser508, Phe478, Ile461, Gly462, Ile416,
Gly509, Ser555, Val463, Ala510, Gly364, Leu365, Gly603

Carvacrol A*

35.08

Arg483
Ser508

HE
OG

O1
H25

2.3
1.8

Tyr525, Phe478, Arg415, Gly509, Ser555, Gln530

Carvacrol S#

37.14

Ser602

OG

H25

1.7

Arg415, Ala556, Tyr334, Gly603, Phe577, Ser363, Asn382, Gly364

#

Notes: *Carvacrol in acidic region; Carvacrol in sulfamide region
Abbreviations: Arg, arginine; Ala, alanine; Gln, glutamine; Gly, glycine; Ile, iso-leucine; Leu, leucine; Phe, phenylalanine; Ser, serine; Tyr, tyrosine; Val, valine.
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to play a pivotal role in designing strategies for cellular
protection.19 Furthermore, our results are in line with pre
vious studies indicating the downregulation of both Nrf2
and its downstream protein HO-1 in a depression model.61
Interestingly, increased levels of ROS and LPO, along
with the downregulation of Nrf2/HO-1, were markedly
recovered in carvacrol-treated animals, validating our pro
posed hypothesis that carvacrol exerts free-radical scaven
ging and antioxidant activity. We previously reported the
antioxidant effect of a similar monoterpene carveol in
ischemic stroke by targeting the Nrf2.25 To rule out the
possible pathway of carvacrol-mediated neuroprotection,
we treated LPS-intoxicated rats with both carvacrol and
ATRA. As per our expectation, ATRA abrogated the neu
roprotective effects of carvacrol by blocking the Nrf2 and
HO-1 signaling pathways, and further, we noticed an
increase in LPO and ROS levels along with a decrease in
antioxidant enzymes (GST, GSH, and catalase) compared
to the LPS-only group. These effects suggest that carvacrol
could reduce depressive- and anxiety-like symptoms by
mediating the Nrf2/HO-1 pathway. In our previous study,
we demonstrated that ATRA increased infarction area by
mediating neuroinflammation in the ischemic stroke
model possibly by antagonizing the Nrf2 pathway.21
Furthermore, Nrf2 can also modulate the level of seroto
nin, noradrenaline, and dopamine, which are the key tar
gets of the monoamine hypothesis. A significant reduction

in the level of these neurotransmitters was shown along
with an elevated level of glutamate in Nrf2 KO mice.28
Activation of Nrf2 signaling inhibits the release of
proinflammatory cytokines and chemokines and downre
gulates the p-NFkB pathway. Consistent studies implicated
inflammatory processes in the pathophysiology of depres
sion not only in laboratory animals but also in meta-ana
lysis and postmortem brain samples.62,63 Moreover, Yao
et al, found a higher level of inflammatory markers in Nrf2
null mice, and which further demonstrated higher immo
bility time (FST).64 In another study, Nrf2 KO mice
demonstrated decrease grooming time in SST,28 which
supports our hypothesis here that Nrf2 antagonism could
exacerbate depression (Figure 2). p-NFkB is a pleiotropic
transcriptional mediator that controls multiple genes asso
ciated with inflammatory cascades and thus induces sev
eral inflammatory cytokines.65 Our findings showed that
carvacrol considerably reduced the LPS-induced expres
sion of p-NFkB, TNFα, and COX2. HO-1, a downstream
target protein of Nrf2, can inhibit proinflammatory
cytokines.66,67 Moreover, activated Nrf2 migrates into the
nucleus, leading to reduced expression of inflammatory
mediators, including COX2.66 Carvacrol significantly
decreased the inflammatory mediators accompanied by
an upregulated expression of the antioxidant HO-1. Both
of these effects were abolished in ATRA-treated groups,
thus supporting our hypothesis that carvacrol can play an

Figure 9 A proposed pathway for the effects of carvacrol pretreatment on LPS-induced oxidative stress, neuroinflammation, and neurodegeneration.
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anti-neuroinflammatory role via activation of the Nrf2/
HO-1 pathway. Moreover, treatment with ATRA further
elevated the level of inflammatory markers, and as such
can exacerbate the depression symptoms due to compro
mised synthesis of dopamine and serotonin.28
Consistent studies have reported the involvement of
MAP kinases, notably JNK, in the propagation of several
degenerative disorders. Moreover, the JNK pathway can
be activated by multiple factors, including ROS and
proinflammatory mediators.68 Likewise, a close interplay
of caspase-3 and JNK is implicated in the execution of
the mitochondrial apoptotic pathway in several neurode
generative disorders.69,70 Our data demonstrated
a considerably decreased expression of anti-apoptotic
Bcl2 as well as a significant increase in the expression
of JNK and caspase-3 in LPS-injected rats. Carvacrol
exhibited a substantial reduction in LPS-provoked eleva
tion of pro-apoptotic proteins and p-JNK associated with
increased anti-apoptotic mediators.

Naeem et al
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Conclusion
In summary, our in vivo results demonstrated that carva
crol could be a potent antioxidant and anti-neuroinflam
matory agent that mediates neuroprotective properties in
LPS-induced depressive- and anxiety-like behaviors.
Further, our proposed neuroprotective mechanism suggests
that carvacrol may activate the master endogenous antiox
idant protein Nrf2 and may be associated with negative
modulation of p-JNK and other neuroinflammatory med
iators (Figure 9), and thus may offer a new therapeutic
option for preventing and managing oxidative stress and
neuroinflammation in neurodegenerative disorders such as
depression and anxiety.
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